Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $34,897 - $38,187
-150 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $8,123 - $8,990
35 Added 30.43%
150 $36,000
Q4 2020

Feb 12, 2021

BUY
$221.92 - $245.94 $25,520 - $28,283
115 New
115 $29,000
Q2 2020

Aug 14, 2020

SELL
$219.9 - $263.41 $78,284 - $93,773
-356 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$236.45 - $266.82 $505,766 - $570,727
-2,139 Reduced 85.73%
356 $97,000
Q3 2019

Nov 14, 2019

SELL
$230.58 - $256.08 $168,553 - $187,194
-731 Reduced 22.66%
2,495 $631,000
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $110,874 - $125,500
-510 Reduced 13.65%
3,226 $813,000
Q1 2019

May 15, 2019

BUY
$206.05 - $248.17 $769,802 - $927,163
3,736 New
3,736 $933,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Kempen Capital Management N.V. Portfolio

Follow Kempen Capital Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempen Capital Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Kempen Capital Management N.V. with notifications on news.